Aizea Morales-Kastresana

Title: Aizea Morales-Kastresana: Innovator in Molecular Nanotags

Introduction

Aizea Morales-Kastresana is a prominent inventor based in Washington, DC. She has made significant contributions to the field of molecular technology, particularly through her innovative work on molecular nanotags. Her research has the potential to advance biomarker and biosignature detection methods.

Latest Patents

Aizea holds a patent for her invention of molecular nanotags. This patent describes a molecular nanotag that includes a core nanoparticle with a diameter of less than about 100 nm. The nanotag may also feature an optional shell surrounding the core and an armor bound to the surface of the core nanoparticle. The molecular nanotag is designed with a functionalized end that has a fixed number of binding sites, allowing it to selectively bind to a molecular targeting ligand. The components of the nanotag contribute to its fluorescence, light scattering, and ligand binding properties, which can be detected by microscopy or devices measuring fluorescence intensity or power. The invention also outlines methods for biomarker and biosignature detection using these molecular tags.

Career Highlights

Aizea is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this esteemed institution has allowed her to focus on groundbreaking research in molecular technology.

Collaborations

Aizea has collaborated with notable colleagues, including Jennifer C. Jones and Jay A. Berzofsky. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.

Conclusion

Aizea Morales-Kastresana is a trailblazer in the field of molecular nanotags, with her patent showcasing her innovative approach to biomarker detection. Her contributions are poised to make a significant impact in the scientific community.